IndiaTickerLatest filing: Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30, 2026, Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015; (B) Other Corporate Matters.
ObservedCompany dossier
Indo Us Bio-Tech
NSE:INDOUS · ISIN INE250Z01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Indo Us Bio-Tech
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 30 Sept 2024 · revenue ₹22.2 Cr · PAT ₹4.4 Cr.
Exchange XBRLLatest ownership: promoter group 68.29% and public 31.71% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30, 2026, Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015; (B) Other Corporate Matters.
BSE · financial results
Observed
Source filing Structural Digital Database - Indo Us Biotech Limited
NSE · exchange filing
Observed
Source filing Indo Us Bio-Tech Ltd - 541304 - Revised Outcome Of The Board Meeting Held On 10 July 2026. Reconstitution Of Committees.
BSE · exchange filing
Observed
Archived filing General Updates - Indo Us Biotech Limited
NSE · exchange filing
Reported financials
Full financials →30 Sept 2024
- Revenue from operations
- ₹22.2 Cr
- Profit after tax
- ₹4.4 Cr
- EPS
- ₹2.16
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 68.29%
- Public
- 31.71%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL